Nevada
|
|
2833
|
|
45-1352286
|
(State or other jurisdiction of incorporation)
|
|
(Primary Standard Industrial
Classification Code Number)
|
|
(I.R.S. Employer Identification No.)
|
1435 Yarmouth Street
|
|
|
|
Boulder, Colorado
|
|
|
80304
|
(Address of principal executive offices)
|
|
|
(Zip Code)
|
Large accelerated filer
|
☐
|
Accelerated filer
|
☐
|
Non-accelerated filer
|
☐
|
Smaller reporting company
|
☒
|
(Do not check if a smaller reporting company)
|
|
|
|
|
Page
|
|
|
|
|
|
|
|
PART I - INFORMATION REQUIRED IN PROSPECTUS
|
||||
|
|
|
|
|
|
|
2
|
|
|
|
|
5
|
|
|
|
|
6
|
|
|
|
|
13
|
|
|
|
|
13
|
|
|
|
|
19
|
|
|
|
|
19
|
|
|
|
|
19
|
|
|
|
|
20
|
|
|
|
|
20
|
|
|
|
|
30
|
|
|
|
|
32
|
|
|
|
|
34
|
|
|
|
|
35
|
|
|
|
|
36
|
|
|
|
|
37
|
|
|
|
|
39
|
|
|
|
|
40
|
|
|
|
|
41
|
|
|
|
|
41
|
|
|
|
|
42
|
|
|
|
|
42
|
|
|
|
|
42
|
|
|
|
|
42
|
|
|
|
|
F-1
|
|
|
|
|
|
|
|
PART II - INFORMATION NOT REQUIRED IN PROSPECTUS
|
||||
|
|
|
|
|
|
II-1
|
|
||
|
II-1
|
|
||
|
II-3
|
|
||
|
II-3
|
|
||
|
II-6
|
|
||
|
II-8
|
|
Securities Offered by the Selling Stockholder
|
5,000,000 shares (1)
|
|
|
Common Stock Outstanding before Offering
|
20,350,003 shares
|
|
|
Common Stock Outstanding after Offering
|
25,350,003 shares, assuming 2,966,664 shares are issued upon conversion or redemption of the Notes, and assuming all 2,033,336 shares are sold to the Selling Stockholder under the Equity Line. If we do not elect to use common stock to pay interest on the Notes or to redeem the Notes, or if we sell less shares of common stock to the Selling Stockholder under the Equity Line, we have substantially less common stock outstanding after the Offering
|
|
|
Use of Proceeds
|
We will not receive any of the proceeds from the sale of the common stock registered hereunder. We will receive proceeds from the delivery of the unissued 10% Notes and our sales of Commitment Shares to the Selling Stockholder under the Equity Line. We intend to use such proceeds, if any, as set forth under “Use of Proceeds” beginning on page 18.
|
|
|
Risk Factors
|
An investment in our securities involves a high degree of risk and could result in a loss of your entire investment. Further, the issuance to, or sale by, the Selling Stockholder of a significant amount of shares being registered in this Registration Statement at any given time could cause the market price of our common stock to decline and to be highly volatile and we do not have the right to control the timing and amount of any sales by the Selling Stockholder of such shares. Prior to making an investment decision, you should carefully consider all of the information in this Prospectus and, in particular, you should evaluate the risk factors set forth under the caption “Risk Factors” beginning on page 6.
|
|
|
Symbol on the OTCQB
|
CLSH
|
(1)
|
Consists of: (i) 2,181,370 shares issuable upon conversion or redemption of the 10% Notes, (ii) 785,294 shares issuable upon conversion or redemption of the 8% Note and (iii) 2,033,336 Commitment Shares issuable in connection with the Equity Line.
|
|
|
Statements of Operations Data:
|
Nine Months Ended
February 29, 2016
|
Nine Months Ended
February 28, 2015
|
Year Ended
May 31, 2015
|
For the Period May 1, 2014 (Inception) through May 31, 2014
|
||||||||||||
(unaudited)
|
(unaudited)
|
|||||||||||||||
Total Revenues
|
$
|
-
|
$
|
-
|
$
|
--
|
$
|
-
|
||||||||
Cost of goods sold
|
$
|
$
|
$
|
-
|
$
|
-
|
||||||||||
Net income (loss)
|
$
|
(1,862,610
|
)
|
$
|
(659,748
|
)
|
$
|
(1,515,587
|
)
|
$
|
-
|
|||||
Net loss per share attributable to common stockholders, basic and diluted
|
$
|
(0.09
|
)
|
$
|
(0.04
|
)
|
$
|
(0.24
|
)
|
$
|
-
|
|||||
Weighted average shares used to compute net loss per share attributable to common stockholders, basic and diluted
|
$
|
20,081,901
|
$
|
15,000,000
|
$
|
6,356,167
|
$
|
-
|
Balance Sheet Data
|
February 29, 2016
|
May 31, 2015
|
May 31, 2014
|
|||||||||
|
(unaudited)
|
|||||||||||
Cash
|
$
|
30,170
|
$
|
208,821
|
$
|
-
|
||||||
Current assets
|
$
|
44,332
|
$
|
240,621
|
$
|
-
|
||||||
Total assets
|
$
|
140,010
|
$
|
292,779
|
$
|
-
|
||||||
Current liabilities
|
$
|
1,082,691
|
$
|
875,696
|
$
|
-
|
||||||
Total Liabilities
|
$
|
1,202,736
|
$
|
881,252
|
$
|
-
|
||||||
Stockholders' equity
|
$
|
(1,062,726
|
)
|
$
|
(588,473
|
)
|
$
|
-
|
||||
Total liabilities and stockholders' equity
|
$
|
140,010
|
$
|
292,779
|
$
|
-
|
|
February 29,
2016
|
May 31,
2015
|
||||||
Current Assets
|
$
|
44,332
|
$
|
240,621
|
||||
Current Liabilities
|
$
|
1,082,691
|
$
|
875,696
|
||||
Working Capital (Deficit)
|
$
|
(1,038,359
|
)
|
$
|
(635,075
|
)
|
Date Paid or Due
|
Type of Payment
|
Amount of Payment
|
|||
March 18, 2016
|
Reimbursement of Legal Fees
|
$
|
10,000
|
||
|
|
||||
September 19, 2016
|
Accrued Interest on 10% Notes and 8% Note
|
$
|
23,731
|
(1)(2)(3)(4)
|
|
|
|
||||
October 3, 2016
|
Accrued Interest on 10% Notes
|
$
|
2,070
|
(1)(2)(3)(4)
|
|
|
|||||
October 17, 2016
|
Accrued Interest on 10% Notes and 8% Note
|
$
|
3,017
|
(1)(2)(3)(4)
|
|
|
||||
October 31, 2016
|
Accrued Interest on 10% Notes
|
$
|
1,890
|
(1)(2)(3)(4)
|
|
November 14, 2016
|
Accrued Interest on 10% Notes and 8% Note
|
$
|
2,630
|
(1)(2)(3)(4)
|
November 28, 2106
|
Accrued Interest on 10% Notes
|
$
|
1,710
|
(1)(2)(3)(4)
|
|
|
|||||
December 12, 2016
|
Accrued Interest on 10% Notes and 8% Note
|
$
|
2,243
|
(1)(2)(3)(4)
|
December 26, 2016
|
Accrued Interest on 10% Notes
|
$
|
1,530
|
(1)(2)(3)(4)
|
|
|
|||||
January 9, 2017
|
Accrued Interest on 10% Notes and 8% Note
|
$
|
1,855
|
(1)(2)(3)(4)
|
|
|
|
||||
January 23, 2017
|
Accrued Interest on 10% Notes
|
$
|
1,350
|
(1)(2)(3)(4)
|
|
|
|
||||
February 6, 2017
|
Accrued Interest on 10% Notes and 8% Note
|
$
|
1,468
|
(1)(2)(3)(4)
|
|
|
|
||||
February 20, 2017
|
Accrued Interest on 10% Notes
|
$
|
1,170
|
(1)(2)(3)(4)
|
|
|
|
||||
March 6, 2017
|
Accrued Interest on 10% Notes
|
$
|
1,080
|
(1)(2)(3)(4)
|
|
|
|
||||
March 20, 2017
|
Accrued Interest on 10% Notes
|
$
|
990
|
(1)(2)(3)(4)
|
|
|
|||||
April 3, 2017
|
Accrued Interest on 10% Notes
|
$
|
900
|
(1)(2)(3)(4)
|
|
|
|
||||
April 17, 2017
|
Accrued Interest on 10% Notes
|
$
|
810
|
(1)(2)(3)(4)
|
|
|
|||||
May 1, 2017
|
Accrued Interest on 10% Notes
|
$
|
720
|
(1)(2)(3)(4)
|
|
|
|
||||
May 15, 2017
|
Accrued Interest on 10% Notes
|
$
|
630
|
(1)(2)(3)(4)
|
|
|
|||||
May 29, 2017
|
Accrued Interest on 10% Notes
|
$
|
540
|
(1)(2)(3)(4)
|
|
|
|
||||
June 12, 2017
|
Accrued Interest on 10% Notes
|
$
|
450
|
(1)(2)(3)(4)
|
|
|
|
||||
June 26, 2017
|
Accrued Interest on 10% Notes
|
$
|
360
|
(1)(2)(3)(4)
|
|
|
|
||||
July 10, 2017
|
Accrued Interest on 10% Notes
|
$
|
270
|
(1)(2)(3)(4)
|
July 24, 2017
|
Accrued Interest on 10% Notes
|
|
$
|
180
|
(1)(2)(3)(4) |
August 7, 2017
|
Accrued Interest on 10% Notes
|
$
|
90
|
(1)(2)(3)(4)
|
Date of Receipt of Proceeds
|
Amount of Proceeds
|
Applicable Note
|
||||
March 18, 2016
|
$
|
190,000
|
10% Notes
|
|||
March 18, 2016
|
$
|
0
|
(1)
|
8% Note
|
||
April 22, 2016
|
$
|
40,000
|
(2)
|
10% Notes
|
||
May 31, 2016
|
$
|
50,000
|
10% Notes
|
|||
[Fifth calendar day after Effective Date]
|
$
|
200,000
|
(3)
|
10% Notes
|
Name
|
Age
|
Position
|
||
Jeffrey Binder
|
69
|
Chairman, President, CEO and Director
|
||
Frank Koretsky
|
53
|
Director
|
||
Alan Bonsett
|
42
|
Chief Operating Officer
|
Name and
Principal Position
|
Fiscal
Year
|
Salary
($)
|
Bonus
($)
|
Option
Awards
($)
|
Non-Equity
Incentive
Plan
Compensation
($)
|
Non-Qualified
Deferred
Compensation
($)
|
All Other
Compensation
($)
|
Total
($)
|
||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||
Larry Adelt,
|
2015
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
||||||||||||||||||||||
Former President and Chief Executive Officer(1)
|
2014
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||
Jeffrey Binder,
|
2015
|
106,250
|
—
|
—
|
—
|
—
|
—
|
106,250
|
||||||||||||||||||||||
Chairman, President and Chief Executive Officer(2)
|
2014
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||
Michael Abrams,
|
2015
|
100,000
|
—
|
—
|
—
|
—
|
—
|
100,000
|
||||||||||||||||||||||
Former Chief Operating Officer(3)
|
2014
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||
Alan Bonsett,
|
2015
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
||||||||||||||||||||||
Chief Operating Officer(4)
|
2014
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
1 | Mr. Adelt resigned as an officer and director of the Company on November 12, 2014 following the sale of all of his shares of common stock in the Company to CLS Labs. On the same date, Jeffrey Binder was appointed Chairman, President and Chief Executive Officer of the Company. |
2 | Mr. Binder was appointed Chairman, President and Chief Executive Officer of the Company on November 12, 2014. Although Mr. Binder’s employment agreement provides for an annual salary of $150,000 per annum; to date, he has deferred all compensation from the Company, including the referenced salary. |
3 | Mr. Abrams earned a salary of $150,000 per annum during the fiscal year ended May 31, 2015 pursuant to his employment agreement. Mr. Abrams resigned as Chief Operating Officer effective August 15, 2015 and was replaced by Alan Bonsett on that date. |
4 | Mr. Bonsett and the Company entered into an employment agreement effective August 1, 2015 and he was appointed Chief Operating Officer of the Company effective August 15, 2015. |
Name and Address of Beneficial Owner
1
|
Amount and Nature of
Beneficial Ownership
2
|
Percentage of Class
3
|
||||||
Jeffrey I. Binder
|
5,000,000
|
24.6
|
%
|
|||||
Raymond Keller
|
5,000,000
|
24.6
|
%
|
|||||
Frank Koretsky
|
5,000,000
|
24.6
|
%
|
|||||
Charles DeAngelo
|
1,096,094
|
5.4
|
%
|
|||||
Marc Douglas
|
1,096,094
|
5.4
|
%
|
|||||
Alan Bonsett
|
250,000
|
1.2
|
%
|
|||||
All directors and executive officers as a group (3 persons)
|
10,250,000
|
50.4
|
%
|
|
Common Stock
|
|||||||
|
High ($)
|
Low ($)
|
||||||
Fiscal Year Ending May 31, 2016:
|
||||||||
Fourth Quarter
|
$
|
1.22
|
$
|
0.85
|
||||
Third Quarter
|
$
|
1.22
|
$
|
0.72
|
||||
Second Quarter
|
$
|
1.31
|
$
|
0.77
|
||||
First Quarter
|
$
|
1.80
|
$
|
0.75
|
||||
Fiscal Year Ended May 31, 2015:
|
||||||||
Fourth Quarter *
|
$
|
0.20
|
$
|
0.20
|
||||
Third Quarter *
|
$
|
0.20
|
$
|
0.20
|
||||
Second Quarter *
|
$
|
0.20
|
$
|
0.20
|
|
Number of Shares of Common Stock
Owned Prior to Offering
|
Maximum Number of Shares of
Common Stock to be Offered
|
Number of Shares of Common Stock
Owned after Offering
|
|||||||||||||||||
Name of Selling Stockholder
|
Number
|
Percent
|
Pursuant to this Prospectus
|
Number (1)
|
Percent
|
|||||||||||||||
Old Main Capital, LLC (2)
|
881,360
|
(3)
|
4.15
|
%
|
5,000,000
|
0
|
*
|
Market price per share at March 18, 2016
1
|
$
|
1.03
|
|||
Conversion price per share at March 18, 2016
2
|
$
|
0.80
|
|||
Total shares underlying Notes
3
|
694,444
|
||||
Aggregate market value of underlying shares based on market price
as of March 18, 2016
|
$
|
715,277
|
|||
Aggregate conversion price of underlying shares
|
$
|
555,555
|
|||
Total dollar amount of discount to market price
|
$
|
159,722
|
|||
Percentage discount to market price
|
22.3
|
%
|
(1)
|
Market price calculated as the average of the high and low prices for the Company’s common stock on March 18, 2016, as reported on the OTC Market Group, Inc.’s OTCQB tier.
|
(2)
|
Pursuant to the terms of the 10% Notes, the conversion price was calculated as 80% of the lowest VWAP (as defined in the 10% Notes) during the 20 trading days prior to March 18, 2016.
|
(3)
|
Assumes issuance of all of the 10% Notes on March 18, 2016.
|
Market price per share at March 18, 2016
1
|
$
|
1.03
|
|||
Conversion price per share at March 18, 2016
2
|
$
|
1.07
|
|||
Total shares underlying Notes
|
186,915
|
||||
Aggregate market value of underlying shares based on market price
as of March 18, 2016
|
$
|
192,522
|
|||
Aggregate conversion price of underlying shares
3
|
$
|
200,000
|
|||
Total dollar amount of premium to market price
|
$
|
7,477
|
|
||
Percentage premium to market price
|
3.88
|
%
|
(1)
|
Market price calculated as the average of the high and low prices for the Company’s common stock on March 18, 2016, as reported on the OTC Market Group, Inc.’s OTCQB tier.
|
(2)
|
Pursuant to the terms of the 8% Note, the conversion price is the average VWAP (as defined in the 8% Note) during the ten days immediately preceding the closing date.
|
(3)
|
The 8% Note was issued in lieu of a $200,000 cash commitment fee in connection with the Equity Purchase Agreement.
|
· | ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers; |
· | block trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction; |
· | purchases by a broker-dealer as principal and resale by the broker-dealer for its account; |
· | exchange distributions in accordance with the rules of the applicable exchange; |
· | privately negotiated transactions; |
· | settlements of short sales; |
· | transactions through broker-dealers that agree with the Selling Stockholders to sell a specified number of such securities at a stipulated price per security; |
· | writings or settlements of options or other hedging transactions, whether through an options exchange or otherwise; |
· | combinations of any such methods of sale; or |
· | any other methods permitted pursuant to applicable law. |
|
Page
|
|
|
F-2
|
|
|
|
F-3
|
|
|
|
F-4
|
|
|
|
F-5
|
|
Page
|
F-16
|
|
|
|
F-17
|
|
|
|
F-18
|
|
|
|
F-19
|
|
|
|
F-20
|
|
|
|
F-21
|
|
February 29,
|
May 31,
|
||||||
|
2016
|
2015
|
||||||
|
(unaudited)
|
|||||||
ASSETS
|
||||||||
Current assets
|
||||||||
Cash and cash equivalents
|
$
|
30,170
|
$
|
208,821
|
||||
Prepaid expenses
|
14,162
|
31,800
|
||||||
Total current assets
|
44,332
|
240,621
|
||||||
|
||||||||
Security deposit
|
50,000
|
50,000
|
||||||
Property, plant and equipment, net of accumulated depreciation of $669 and $0
|
2,005
|
-
|
||||||
Construction in progress
|
41,803
|
-
|
||||||
Note receivable related party, noncurrent, net of allowance of $500,000 and $500,000
|
-
|
-
|
||||||
Intangible assets, net of accumulated amortization of $288 and $0
|
1,870
|
2,158
|
||||||
Total assets
|
$
|
140,010
|
$
|
292,779
|
||||
|
||||||||
LIABILITIES AND STOCKHOLDERS' EQUITY
|
||||||||
Current liabilities
|
||||||||
Accounts payable and accrued liabilities
|
$
|
343,488
|
$
|
145,024
|
||||
Deferred rent liability
|
47,888
|
-
|
||||||
Accrued compensation, related party
|
212,500
|
106,250
|
||||||
Due to related party
|
17,930
|
18,455
|
||||||
Accrued interest
|
25,151
|
2,630
|
||||||
Accrued interest, related party
|
42,984
|
3,337
|
||||||
Notes payable, related party
|
392,750
|
600,000
|
||||||
Total current liabilities
|
1,082,691
|
875,696
|
||||||
|
||||||||
Noncurrent liabilities
|
||||||||
Related party convertible notes, net of debt discount of $880,510 and $0
|
64,489
|
-
|
||||||
Convertible notes payable, net of debt discount of $144,444 and $194,444
|
55,556
|
5,556
|
||||||
Total Liabilities
|
1,202,736
|
881,252
|
||||||
|
||||||||
Commitments and contingencies
|
-
|
-
|
||||||
|
||||||||
Stockholder's equity
|
||||||||
Common stock, $0.0001 par value; 250,000,000 shares authorized; 20,320,003 and 20,000,003 shares issued and outstanding at February 29, 2016 and May 31, 2015
|
2,032
|
2,000
|
||||||
Preferred stock, $0.001 par value; 20,000,000 shares authorized; no shares issued
|
-
|
-
|
||||||
Additional paid-in capital
|
2,217,989
|
887,614
|
||||||
Stock payable
|
95,450
|
37,500
|
||||||
Accumulated deficit
|
(3,378,197
|
)
|
(1,515,587
|
)
|
||||
Total stockholder's equity (deficit)
|
(1,062,726
|
)
|
(588,473
|
)
|
||||
|
||||||||
Total liabilities and stockholders' equity (deficit)
|
$
|
140,010
|
$
|
292,779
|
|
For the Three
|
For the Three
|
For the Nine
|
For the Nine
|
||||||||||||
|
Months Ended
|
Months Ended
|
Months Ended
|
Months Ended
|
||||||||||||
|
February 29,
|
February 28,
|
February 29,
|
February 28,
|
||||||||||||
|
2016
|
2015
|
2016
|
2015
|
||||||||||||
|
||||||||||||||||
Revenue
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
||||||||
Cost of goods sold
|
-
|
-
|
-
|
-
|
||||||||||||
Gross margin
|
-
|
-
|
-
|
-
|
||||||||||||
|
||||||||||||||||
Selling, general and administrative expenses
|
406,323
|
152,375
|
917,726
|
362,453
|
||||||||||||
Professional fees
|
343,818
|
186,279
|
767,420
|
296,850
|
||||||||||||
Total operating expenses
|
750,141
|
338,654
|
1,685,146
|
659,303
|
||||||||||||
|
||||||||||||||||
Operating loss
|
(750,141
|
)
|
(338,654
|
)
|
(1,685,146
|
)
|
(659,303
|
)
|
||||||||
|
||||||||||||||||
Other (income) expense:
|
||||||||||||||||
Interest expense
|
106,599
|
265
|
177,464
|
445
|
||||||||||||
Total other expense
|
106,599
|
265
|
177,464
|
445
|
||||||||||||
|
||||||||||||||||
Income (Loss) before income taxes
|
(856,740
|
)
|
(338,919
|
)
|
(1,862,610
|
)
|
(659,748
|
)
|
||||||||
|
||||||||||||||||
Income tax expense
|
-
|
-
|
-
|
-
|
||||||||||||
|
||||||||||||||||
Net income (loss)
|
$
|
(856,740
|
)
|
$
|
(338,919
|
)
|
$
|
(1,862,610
|
)
|
$
|
(659,748
|
)
|
||||
|
||||||||||||||||
Net income (loss) per share - basic
|
$
|
(0.04
|
)
|
$
|
(0.02
|
)
|
$
|
(0.09
|
)
|
$
|
(0.04
|
)
|
||||
|
||||||||||||||||
Net income (loss) per share - diluted
|
$
|
(0.04
|
)
|
$
|
(0.02
|
)
|
$
|
(0.09
|
)
|
$
|
(0.04
|
)
|
||||
|
||||||||||||||||
Weighted average shares outstanding - basic
|
20,182,640
|
15,000,000
|
20,081,901
|
15,000,000
|
||||||||||||
|
||||||||||||||||
Weighted average shares outstanding - diluted
|
20,182,640
|
15,000,000
|
20,081,901
|
15,000,000
|
|
For the Nine
|
For the Nine
|
||||||
|
Months Ended
|
Months Ended
|
||||||
|
February 29,
|
February 28,
|
||||||
|
2016
|
2015
|
||||||
CASH FLOWS FROM OPERATING ACTIVITIES
|
||||||||
Net income (loss)
|
$
|
(1,862,610
|
)
|
$
|
(659,748
|
)
|
||
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||||||
Imputed interest
|
807
|
445
|
||||||
Issuance of stock for services
|
115,050
|
-
|
||||||
Stock-based compensation
|
327,500
|
-
|
||||||
Amortization of debt discount
|
114,489
|
-
|
||||||
Depreciation and amortization expense
|
957
|
-
|
||||||
Changes in assets and liabilities:
|
||||||||
Due from related parties
|
-
|
(6,497
|
)
|
|||||
Prepaid expenses
|
17,638
|
(102,216
|
)
|
|||||
Accounts payable and accrued expenses
|
198,464
|
111,932
|
||||||
Deferred liabilities
|
47,888
|
-
|
||||||
Accrued compensation, related party
|
106,250
|
68,750
|
||||||
Due to related parties
|
(525
|
)
|
17,930
|
|||||
Accrued interest, related party
|
39,647
|
-
|
||||||
Accrued interest
|
22,521
|
-
|
||||||
|
||||||||
Net cash used in operating activities
|
(871,924
|
)
|
(569,404
|
)
|
||||
|
||||||||
CASH FLOWS FROM INVESTING ACTIVITIES
|
||||||||
Payments to acquire equipment
|
(2,674
|
)
|
-
|
|||||
Payment for construction in progress
|
(41,803
|
)
|
-
|
|||||
Payments to acquire intangible assets
|
-
|
(2,158
|
)
|
|||||
Payments for investment in shell company
|
-
|
(295,250
|
)
|
|||||
|
||||||||
Net cash used in investing activities
|
(44,477
|
)
|
(297,408
|
)
|
||||
|
||||||||
CASH FLOWS FROM FINANCING ACTIVITIES
|
||||||||
Proceeds from sale of common stock
|
-
|
1,000,000
|
||||||
Proceeds from related party convertible notes payable
|
345,000
|
|||||||
Proceeds from related party notes payable
|
392,750
|
-
|
||||||
|
||||||||
Net cash provided by financing activities
|
737,750
|
1,000,000
|
||||||
|
||||||||
Net increase in cash and cash equivalents
|
(178,651
|
)
|
133,188
|
|||||
|
||||||||
Cash and cash equivalents at beginning of period
|
208,821
|
-
|
||||||
|
||||||||
Cash and cash equivalents at end of period
|
$
|
30,170
|
$
|
425,302
|
||||
|
||||||||
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
|
||||||||
Interest paid
|
$
|
-
|
$
|
-
|
||||
Income taxes paid
|
$
|
-
|
$
|
-
|
||||
|
||||||||
NON-CASH INVESTING AND FINANCING ACTIVITIES:
|
||||||||
Stock issued to founder for intellectual property
|
$
|
-
|
$
|
500
|
||||
Discount on notes payable
|
$
|
945,000
|
$
|
-
|
||||
Transfer principle from related party notes payable to related party convertible notes payable
|
$
|
945,000
|
$
|
-
|
|
Three Months
|
Nine Months
|
||||||
|
Ended
|
Ended
|
||||||
|
February 28,
|
February 28,
|
||||||
|
2015
|
2015
|
||||||
Total revenue
|
$
|
-
|
$
|
-
|
||||
Net loss attributable to CLS Holdings USA, Inc.
|
(338,919
|
)
|
(659,748
|
)
|
||||
Basic net income (loss) per common share
|
(0.02
|
)
|
(0.04
|
)
|
||||
Diluted net income (loss) per common share
|
(0.02
|
)
|
(0.04
|
)
|
||||
Weighted average shares - basic
|
15,000,000
|
15,000,000
|
||||||
Weighted average shares - diluted
|
15,000,000
|
15,000,000
|
|
February 29,
|
May 31,
|
||||||
|
2016
|
2015
|
||||||
Prepaid legal fees
|
8,162
|
3,466
|
||||||
Prepaid consulting fees
|
1,000
|
28,334
|
||||||
Other prepaid expenses
|
5,000
|
-
|
||||||
Total
|
$
|
14,162
|
$
|
31,800
|
|
February 29,
|
May 31,
|
||||||
|
2016
|
2015
|
||||||
Computer equipment
|
$
|
2,674
|
$
|
-
|
||||
Property and equipment, gross
|
2,674
|
-
|
||||||
Less: accumulated depreciation
|
(669
|
)
|
-
|
|||||
Property and equipment, net
|
$
|
2,005
|
$
|
-
|
|
February 29,
|
May 31,
|
||||||
|
2016
|
2015
|
||||||
Domain name
|
$
|
2,158
|
$
|
2,158
|
||||
|
2,158
|
2,158
|
||||||
Less: accumulated amortization
|
(288
|
)
|
-
|
|||||
Intangible assets, net
|
$
|
1,870
|
$
|
2,158
|
|
May 31
|
May 31
|
||||||
|
2015
|
2014
|
||||||
ASSETS
|
||||||||
Current assets
|
||||||||
Cash and cash equivalents
|
$
|
208,821
|
$
|
-
|
||||
Prepaid expenses
|
31,800
|
-
|
||||||
Note receivable, current, net of allowance of $100,000
|
-
|
-
|
||||||
Total current assets
|
240,621
|
-
|
||||||
|
||||||||
Security deposit
|
50,000
|
-
|
||||||
Note receivable, noncurrent, net of allowance of $400,000
|
-
|
-
|
||||||
Intangible assets, net
|
2,158
|
-
|
||||||
Total assets
|
$
|
292,779
|
$
|
-
|
||||
|
||||||||
LIABILITIES AND STOCKHOLDERS' EQUITY
|
||||||||
Current liabilities
|
||||||||
Accounts payable and accrued liabilities
|
$
|
145,024
|
$
|
-
|
||||
Accrued compensation, related party
|
106,250
|
-
|
||||||
Due to related party
|
18,455
|
-
|
||||||
Accrued interest
|
2,630
|
-
|
||||||
Accrued interest, related party
|
3,337
|
-
|
||||||
Notes payable, related party
|
600,000
|
-
|
||||||
Total current liabilities
|
875,696
|
-
|
||||||
|
||||||||
Noncurrent liabilities
|
||||||||
Convertible notes payable, net of debt discount
|
5,556
|
-
|
||||||
Total Liabilities
|
881,252
|
-
|
||||||
|
||||||||
Commitments and contingencies
|
-
|
-
|
||||||
|
||||||||
Stockholder's equity
|
||||||||
Common stock, $0.0001 par value; 250,000,000 shares authorized; 20,000,003 and zero shares issued and outstanding at May 31, 2015 and 2014
|
2,000
|
-
|
||||||
Additional paid-in capital
|
887,614
|
-
|
||||||
Stock payable
|
37,500
|
-
|
||||||
Accumulated deficit
|
(1,515,587
|
)
|
-
|
|||||
Total stockholder's equity
|
(588,473
|
)
|
-
|
|||||
|
||||||||
Total liabilities and stockholders' equity
|
$
|
292,779
|
$
|
-
|
|
For the Period
|
|||||||
|
May 1, 2014
|
|||||||
|
For the Year
|
(Inception)
|
||||||
|
Ended
|
Through
|
||||||
|
May 31,
|
May 31,
|
||||||
|
2015
|
2014
|
||||||
|
||||||||
Revenue
|
$
|
-
|
$
|
-
|
||||
Cost of goods sold
|
-
|
-
|
||||||
Gross margin
|
-
|
-
|
||||||
|
||||||||
Selling, general and administrative expenses
|
998,994
|
-
|
||||||
Professional fees
|
504,354
|
-
|
||||||
Total operating expenses
|
1,503,348
|
-
|
||||||
|
||||||||
Operating loss
|
(1,503,348
|
)
|
-
|
|||||
|
||||||||
Other (income) expense:
|
||||||||
Interest expense
|
12,239
|
-
|
||||||
Total other expense
|
12,239
|
-
|
||||||
|
||||||||
Income (Loss) before income taxes
|
(1,515,587
|
)
|
-
|
|||||
|
||||||||
Income tax expense
|
-
|
-
|
||||||
|
||||||||
Net income (loss)
|
$
|
(1,515,587
|
)
|
$
|
-
|
|||
|
||||||||
Net income (loss) per share - basic
|
$
|
(0.24
|
)
|
$
|
-
|
|||
|
||||||||
Net income (loss) per share - diluted
|
$
|
(0.24
|
)
|
$
|
-
|
|||
|
||||||||
Weighted average shares outstanding - basic
|
6,356,167
|
-
|
||||||
|
||||||||
Weighted average shares outstanding - diluted
|
6,356,167
|
-
|
|
Additional
|
|||||||||||||||||||||||
|
Common Stock
|
Paid In
|
Stock
|
Accumulated
|
||||||||||||||||||||
|
Amount
|
Value
|
Capital
|
Payable
|
Deficit
|
Total
|
||||||||||||||||||
|
||||||||||||||||||||||||
Balance, May 1, 2014 (inception)
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||
Net loss
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||
Balance at May 31, 2014
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||
|
||||||||||||||||||||||||
Issuance of founders shares
|
15,000,000
|
1,500
|
998,500
|
-
|
-
|
1,000,000
|
||||||||||||||||||
Effect of reverse merger
|
5,000,003
|
500
|
(311,602
|
)
|
-
|
-
|
(311,102
|
)
|
||||||||||||||||
Imputed interest
|
-
|
-
|
716
|
-
|
-
|
716
|
||||||||||||||||||
Value of vested portion of shares to be issued to a service provider
|
-
|
-
|
-
|
37,500
|
-
|
37,500
|
||||||||||||||||||
Discount due to beneficial conversion feature and warrants
|
-
|
-
|
200,000
|
-
|
-
|
200,000
|
||||||||||||||||||
Net loss
|
-
|
-
|
-
|
-
|
(1,515,587
|
)
|
(1,515,587
|
)
|
||||||||||||||||
Balance, May 31, 2015
|
20,000,003
|
2,000
|
887,614
|
37,500
|
(1,515,587
|
)
|
(588,473
|
)
|
|
For the Period
|
|||||||
|
May 1, 2014
|
|||||||
|
For the
|
(Inception)
|
||||||
|
Year Ended
|
Through
|
||||||
|
May 31
|
May 31,
|
||||||
|
2015
|
2014
|
||||||
CASH FLOWS FROM OPERATING ACTIVITIES
|
||||||||
Net income (loss)
|
$
|
(1,515,587
|
)
|
$
|
-
|
|||
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||||||
Imputed interest
|
716
|
-
|
||||||
Impairment of note receivable
|
500,000
|
-
|
||||||
Stock-based compensation
|
37,500
|
-
|
||||||
Amortization of debt discount
|
5,556
|
-
|
||||||
Changes in assets and liabilities:
|
||||||||
Deposits
|
(50,000
|
)
|
-
|
|||||
Prepaid expenses
|
(38,955
|
)
|
-
|
|||||
Accounts payable and accrued expenses
|
136,327
|
-
|
||||||
Accrued compensation, related party
|
106,250
|
-
|
||||||
Due to related parties
|
18,455
|
-
|
||||||
Accrued interest, related party
|
3,337
|
-
|
||||||
Accrued interest
|
2,630
|
-
|
||||||
|
||||||||
Net cash used in operating activities
|
(793,771
|
)
|
-
|
|||||
|
||||||||
CASH FLOWS FROM INVESTING ACTIVITIES
|
||||||||
Payment of cash for note receivable
|
(500,000
|
)
|
-
|
|||||
Payments to acquire intangible assets
|
(2,158
|
)
|
-
|
|||||
Payments for investment in shell company
|
(295,250
|
)
|
-
|
|||||
|
||||||||
Net cash used in investing activities
|
(797,408
|
)
|
-
|
|||||
|
||||||||
CASH FLOWS FROM FINANCING ACTIVITIES
|
||||||||
Proceeds from sale of common stock
|
1,000,000
|
-
|
||||||
Proceeds from related party note
|
600,000
|
-
|
||||||
Proceeds from issuance of convertible note
|
200,000
|
-
|
||||||
|
||||||||
Net cash provided by financing activities
|
1,800,000
|
-
|
||||||
|
||||||||
Net increase in cash and cash equivalents
|
208,821
|
-
|
||||||
|
||||||||
Cash and cash equivalents at beginning of period
|
-
|
-
|
||||||
|
||||||||
Cash and cash equivalents at end of period
|
$
|
208,821
|
$
|
-
|
||||
|
||||||||
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
|
||||||||
Interest paid
|
$
|
-
|
$
|
-
|
||||
Income taxes paid
|
$
|
-
|
$
|
-
|
||||
|
||||||||
NON-CASH INVESTING AND FINANCING ACTIVITIES:
|
||||||||
Discount due to beneficial conversion feature and warrants
|
$
|
200,000
|
$
|
-
|
||||
Stock issued to founder for intellectual property
|
$
|
500
|
$
|
-
|
||||
Effect of reverse merger
|
$
|
16,352
|
$
|
-
|
|
Twelve months ended
|
|||
|
May 31, 2015
|
|||
Total Revenue
|
-
|
|||
Net loss attributable to CLS Holdings USA, Inc.
|
(2,200,788
|
)
|
||
Basic net income (loss) per common share
|
(0.35
|
)
|
||
Diluted net income (loss) per common share
|
(0.35
|
)
|
||
Weighted average shares - basic
|
6,356,167
|
|||
Weighted average shares - diluted
|
6,356,167
|
|
May 31,
|
May 31,
|
||||||
|
2015
|
2014
|
||||||
Prepaid legal fee
|
$
|
3,466
|
$
|
-
|
||||
Prepaid consulting fees
|
28,334
|
-
|
||||||
Total prepaid expenses
|
$
|
31,800
|
$
|
-
|
|
May 31,
|
May 31,
|
||||||
|
2015
|
2014
|
||||||
Federal and State Statutory Rate
|
35
|
%
|
35
|
%
|
||||
Net operating loss carry forwards
|
500,417
|
-
|
||||||
Valuation allowance for deferred tax assets
|
(500,417
|
)
|
-
|
|||||
Net deferred tax assets
|
-
|
-
|
i. | a Licensing Agreement with Picture Rock Holdings, LLC, a Colorado limited liability company (“PRH”), whereby, in exchange for a license fee payable over the ten (10) year term of the agreement, CLS Labs Colorado granted to PRH an exclusive license for the State of Colorado of certain proprietary inventions and formulas relating to the extraction from, separation and processing (the “Process”) of marijuana to produce certain marijuana-infused products, including edibles, e-liquids, waxes and shatter (the “Products”), and to practice and use the Process in conjunction with the manufacture, production, sale, and distribution of the Products. Pursuant to the Licensing Agreement, if during its term applicable state and local laws change to permit, in whole or in part, the ownership or issuance of a marijuana-infused products license in Colorado (a “MIP License”), directly or indirectly, by or to a person or entity who is not a Colorado resident, CLS Labs Colorado has the option to demand the transfer of up to a fifty six percent (56%) ownership interest in the MIP Licenses owned by PRH to CLS Labs Colorado or its designees in exchange for a proportionate reduction in license fees. |
ii. | an Industrial Lease Agreement (the “Lease”) with Casmir-Quince, LLC, a Colorado limited liability company, whereby CLS Labs Colorado leased 14,392 square feet of warehouse and office space (the “Leased Real Property”) in a building in Denver, Colorado where certain intended activities, including growing, extraction, conversion, assembly and packaging of cannabis and other plant materials, are permitted by and in compliance with state, city and local laws, rules, ordinances and regulations. The Lease has an initial term of seventy-two (72) months and provides CLS Labs Colorado with two options to extend the term of the lease by up to an aggregate of ten (10) additional years. |
iii. | a Sublease Agreement with PRH (the “Sublease”), thereby subletting the entire Leased Real Property to PRH. The term of the Sublease is the same as the Lease and PRH is required to pay CLS Labs Colorado monthly rent equal to the total rent due under the Lease for the corresponding month. |
iv. | an Equipment Lease Agreement (the “Equipment Lease”) with PRH, whereby, in exchange for a lease payment, CLS Labs Colorado agreed to commence building a fully equipped lab at the Leased Real Property, including purchasing all equipment necessary to extract, convert and provide quality control of all cannabis products of PRH. The Equipment Lease terminates upon the earlier of ten (10) years from its effective date or such earlier date upon which the Lease is terminated. PRH has the option to renew the Equipment Lease for a period of five (5) years, or such lesser period as remains under the Lease at the time of the renewal. If during the term of the Equipment Lease applicable state and local laws change to permit, in whole or in part, the ownership or issuance of an MIP License, directly or indirectly, by or to a person or entity who is not a Colorado resident, CLS Labs Colorado has the option to demand the transfer of up to a fifty six percent (56%) ownership interest in the MIP Licenses owned by PRH to CLS Labs Colorado or its designees in exchange for a proportionate reduction in lease payments. |
v. | a promissory note (the “Note”) pursuant to which CLS Labs Colorado loaned Five Hundred Thousand Dollars ($500,000) to PRH to be used by PRH in connection with the financing of the building out, equipping, and development of the Grow Facility by PRH that will be operated by a licensed third-party marijuana grower. PRH will repay the principal due under the Note in twenty (20) equal quarterly installments of Twenty Five Thousand Dollars ($25,000) commencing on July 1, 2015 and continuing until paid in full. Interest will accrue on the unpaid principal balance of the Note at the rate of twelve percent (12%) per annum and will be paid quarterly in arrears commencing on July 1, 2015 and continuing until paid in full. All outstanding principal and any accumulated unpaid interest due under the Note is due and payable on April 1, 2020. |
SEC registration fee
|
$
|
513.57
|
||
Accounting fees and expenses*
|
$
|
4,000
|
||
Legal fees and expenses*
|
$
|
50,000.00
|
||
Printing expenses*
|
$
|
10,000.00
|
||
Miscellaneous fees and expenses*
|
$
|
10,000.00
|
||
Total*
|
$
|
74,513.57
|
Exhibit
|
Description
|
|
2.1
|
Agreement and Plan of Merger dated April 28, 2015 by and among CLS Holdings USA, Inc., CLS Merger, Inc., and CLS Labs, Inc. (incorporated by reference from Exhibit 2.1 in the Company's Current Report on Form 8-K filed with the SEC on April 30, 2015).
|
|
3.1
|
Articles of Incorporation of Adelt Design, Inc. (incorporated by reference from Exhibit 3.1 in the Company's Registration Statement filed with the SEC on June 3, 2011).
|
|
3.2
|
Amended and Restated Articles of Incorporation of CLS Holdings USA, Inc. (incorporated by reference from Exhibit 1.1 in the Company's Current Report on Form 8-K filed with the SEC on November 26, 2014).
|
|
3.3
|
Bylaws of Adelt Design, Inc. (incorporated by reference from Exhibit 3.3 in the Company's Registration Statement filed with the SEC on June 3, 2011).
|
|
3.4
|
Amended and Restated Bylaws of CLS Holdings USA, Inc. (incorporated by reference from Exhibit 1.2 in the Company's Current Report on Form 8-K filed with the SEC on November 26, 2014).
|
4.1
|
Form of Stock Certificate (incorporated by reference from Exhibit 4.1 in the Company's Current Report on Form 8-K filed with the SEC on April 30, 2015).
|
5.1
|
Legal opinion of ___________________ .***
|
10.1
|
Employment Agreement dated October 1, 2014 between CLS Labs, Inc. and Jeffrey Binder (incorporated by reference from Exhibit 10.1 in the Company's Current Report on Form 8-K filed with the SEC on April 30, 2015) (1).
|
10.2
|
Addendum to Employment Agreement dated April 28, 2015 between CLS Labs, Inc., CLS Holdings USA, Inc. and Jeffrey Binder (incorporated by reference from Exhibit 10.2 in the Company's Current Report on Form 8-K filed with the SEC on April 30, 2015) (1).
|
10.3
|
Employment Agreement dated October 1, 2014 between CLS Labs, Inc. and Michael Abrams (incorporated by reference from Exhibit 10.3 in the Company's Current Report on Form 8-K filed with the SEC on April 30, 2015) (1).
|
10.4
|
Addendum to Employment Agreement dated April 28, 2015 between CLS Labs, Inc., CLS Holdings USA, Inc. and Michael Abrams (incorporated by reference from Exhibit 10.4 in the Company's Current Report on Form 8-K filed with the SEC on April 30, 2015) (1).
|
10.5
|
Lease dated April 17, 2015 between Casimir-Quince, LLC, and CLS Labs Colorado, Inc. (incorporated by reference from Exhibit 10.5 in the Company's Current Report on Form 8-K filed with the SEC on April 30, 2015).
|
10.6
|
Sublease Agreement dated April 17, 2015 between CLS Labs Colorado, Inc. and Picture Rock Holdings, LLC (incorporated by reference from Exhibit 10.6 in the Company's Current Report on Form 8-K filed with the SEC on April 30, 2015).
|
10.7
|
Licensing Agreement dated April 17, 2015 between CLS Labs Colorado, Inc. and Picture Rock Holdings, LLC (incorporated by reference from Exhibit 10.7 in the Company's Current Report on Form 8-K filed with the SEC on April 30, 2015).**
|
10.8
|
Equipment Lease dated April 17, 2015, between CLS Labs Colorado, Inc. and Picture Rock Holdings, LLC (incorporated by reference from Exhibit 10.8 in the Company's Current Report on Form 8-K filed with the SEC on April 30, 2015).**
|
10.9
|
Restricted Stock Grant Agreement dated April 28, 2015 between CLS Holdings USA, Inc. and Michael Abrams (incorporated by reference from Exhibit 10.9 in the Company's Current Report on Form 8-K filed with the SEC on April 30, 2015) (1).
|
10.10
|
Subscription for Property Agreement dated July 16, 2014, between CLS Labs, Inc. and Raymond Keller (incorporated by reference from Exhibit 2.1 in the Company's Current Report on Form 8-K filed with the SEC on April 30, 2015.
|
10.11
|
Promissory Note dated April 17, 2015, between CLS Labs Colorado, Inc. and Picture Rock Holdings, LLC (incorporated by reference from Exhibit 10.11 in the Company's Current Report on Form 8-K filed with the SEC on April 30, 2015).
|
10.12
|
Confidentially, Non-Compete and Proprietary Rights Agreement dated July 16, 2104 between CLS Labs, Inc. and Raymond Keller (incorporated by reference from Exhibit 2.1 in the Company's Current Report on Form 8-K filed with the SEC on April 30, 2015).
|
10.13
|
Employment Agreement dated August 18, 2015 between CLS Holdings USA, Inc. and Alan Bonsett (incorporated by reference from Exhibit 10.1 on the Company's Current Report on Form 8-K filed with the SEC on August 20, 2015) (1).
|
10.14
|
Loan Agreement dated April 29, 2015 (incorporated by reference from Exhibit 10.1 in the Company's Current Report on Form 8-K filed with the SEC on May 5, 2015).
|
10.15
|
Form of Indemnification Agreement (incorporated by reference from Exhibit 10.1 in the Company's Current Report on Form 8-K filed with the SEC on December 22, 2105).
|
10.16
|
Convertible Promissory Note dated January 12, 2016 in favor of Frank Koretsky (incorporated by reference from Exhibit 10.1 in the Company's Current Report on Form 8-K filed with the SEC on January 19, 2016).
|
10.17
|
Convertible Promissory Note dated January 12, 2016, in favor of Jeffrey Binder (incorporated by reference from Exhibit 10.2 in the Company's Current Report on Form 8-K filed with the SEC on January 19, 2016) (1).
|
10.18
|
10% Original Issue Discount Convertible Promissory Note dated March 18, 2016, in favor of Old Main Capital, LLC (incorporated by reference from Exhibit 4.1 in the Company's Current Report on Form 8-K filed with the SEC on March 24, 2016).
|
10.19
|
8% Convertible Promissory Note dated March 18, 2016 in favor of Old Main Capital, LLC (incorporated by reference from Exhibit 4.2 in the Company's Current Report on Form 8-K filed with the SEC on March 24, 2016).
|
10.20
|
|
10.21
|
Registration Rights Agreement dated March 18, 2016 between the Company and Old Main Capital, LLC (incorporated by reference from Exhibit 10.2 in the Company's Current Report on Form 8-K filed with the SEC on March 24, 2016).
|
10.22
|
Convertible Promissory Note dated April 11, 2016, in favor of Frank Koretsky (incorporated by reference from Exhibit 10.1 in the Company's Current Report on Form 8-K filed with the SEC on April 14, 2016).
|
10.23
|
Convertible Promissory Note dated April 11, 2016, in favor of Jeffrey Binder (incorporated by reference from Exhibit 10.2 in the Company's Current Report on Form 8-K filed with the SEC on April 14, 2016).
|
10.24
|
Equity Purchase Agreement dated April 18, 2016 between the Company and Old Main Capital, LLC (incorporated by reference from Exhibit 10.1 in the Company's Current Report on Form 8-K filed with the SEC on April 20, 2016).
|
21.1
|
Subsidiaries of CLS Holdings USA, Inc. (incorporated by reference from Exhibit 21.1 in the Company’s Registration Statement on Form S-1 filed with the SEC on April 21, 2016).
|
23.1
|
|
23.2
|
Consent of ____________________ (included in Exhibit 5.1).***
|
24.1
|
Power of Attorney of Directors of the Registrant (set forth on signature page to this filing).
|
*
|
Filed herewith
|
** | Portions of this document are omitted pursuant to a confidential treatment order granted pursuant to Rule 24(b)-2 under the Exchange Act. Confidential portions of this document have been filed separately with the Securities and Exchange Commission. |
*** | To be filed by amendment. |
Signatures
|
Title
|
Date
|
||
/s/ Jeffrey I. Binder
|
Chairman, President, Chief Executive Officer and Director
|
June 2, 2016
|
||
Jeffrey I. Binder
|
(principal executive officer and principal financial officer)
|
|||
*
|
Director
|
June 2, 2016
|
||
Frank Koretsky
|
(i)
|
Material Changes; Undisclosed Events, Liabilities or Developments
. Since the date of the latest unaudited financial statements included within the SEC Reports, except as specifically disclosed in a subsequent SEC Report filed prior to the date hereof: (i) there has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect; (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the Company’s financial statements pursuant to GAAP or disclosed in filings made with the Commission; (iii) the Company has not altered its method of accounting; (iv) the Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock; and (v)
the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company stock option plans and other than as set forth on
Schedule 3.1(i)
.
The Company does not have pending before the Commission any request for confidential treatment of information. Except for the issuance of the Securities contemplated by this Agreement, no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, properties, operations, assets or financial condition, that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed at least one (1) Trading Day prior to the date that this representation is made.
|
CLS Holdings USA Inc.
|
Address for Notice:
CLS Holdings USA, Inc.
11767 S. Dixie Highway, Suite 115
Miami, Florida 33156
|
By:__________________________________________
Name: Jeffrey I. Binder
Title: Chairman and CEO
Phone Number (for confirmation of receipt of emails):
(305) ___________________________
With a copy to (which shall not constitute notice):
Broad and Cassel
1 N. Clematis Street, Suite 500
West Palm Beach, FL 33401
Attention: Kathleen L. Deutsch, P.A.
|
conversionnotice@broadandcassel.com
|
Disbursement Date: | March 18, 2016 |